Swiss - Delayed Quote CHF
Galenica AG (GALE.SW)
85.00
-2.05
(-2.35%)
At close: May 12 at 5:30:25 PM GMT+2
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
3,921,081
3,921,081
3,746,011
3,588,456
3,834,679
Cost of Revenue
2,833,749
2,833,749
2,704,432
2,603,158
2,866,863
Gross Profit
1,087,332
1,087,332
1,041,579
985,298
967,816
Operating Expense
882,978
882,978
851,642
799,266
778,378
Operating Income
204,354
204,354
189,937
186,032
189,438
Net Non Operating Interest Income Expense
-10,794
-10,794
-13,855
-4,278
-4,405
Pretax Income
214,597
214,597
194,949
189,614
203,033
Tax Provision
30,898
30,898
29,245
32,267
34,850
Net Income Common Stockholders
182,951
182,951
285,367
165,132
167,680
Diluted NI Available to Com Stockholders
182,951
182,951
285,367
165,132
167,680
Basic EPS
3.67
3.67
5.72
3.32
3.38
Diluted EPS
3.67
3.67
5.72
3.32
3.38
Basic Average Shares
49,842.93
49,842.93
49,848.22
49,734.84
49,569.69
Diluted Average Shares
49,886.23
49,886.23
49,894.95
49,803.57
49,631.53
Total Operating Income as Reported
--
--
--
203,310
207,408
Rent Expense Supplemental
10,510
10,510
10,997
10,998
9,009
Total Expenses
3,716,727
3,716,727
3,556,074
3,402,424
3,645,241
Net Income from Continuing & Discontinued Operation
182,951
182,951
285,367
165,132
167,680
Normalized Income
171,172.83
171,172.83
155,362.13
154,844.98
159,907.56
Interest Income
2,017
2,017
1,878
1,160
738
Interest Expense
12,654
12,654
9,466
5,239
5,017
Net Interest Income
-10,794
-10,794
-13,855
-4,278
-4,405
EBIT
227,251
227,251
204,415
194,853
208,050
EBITDA
336,980
336,980
307,415
294,425
306,480
Reconciled Cost of Revenue
2,833,749
2,833,749
2,704,432
2,603,158
2,866,863
Reconciled Depreciation
109,729
109,729
103,000
99,572
98,430
Net Income from Continuing Operation Net Minority Interest
183,031
183,031
164,919
156,620
167,680
Total Unusual Items Excluding Goodwill
13,853
13,853
10,726
2,136
9,387
Total Unusual Items
13,853
13,853
10,726
2,136
9,387
Normalized EBITDA
323,127
323,127
296,689
292,289
297,093
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
1,994.83
1,994.83
1,169.13
360.98
1,614.56
12/31/2021 - 4/7/2017
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
AMPm.XC
AMFPF Amplifon S.p.A.
22.02
0.00%
NVLG.TA Novolog (Pharm-Up 1966) Ltd
152.60
-1.93%
ARJO-B.ST Arjo AB (publ)
31.50
+1.35%
AMP.VI Amplifon S.p.A.
19.25
+2.86%
QIPT.TO Quipt Home Medical Corp.
2.9800
-1.32%
EDAP EDAP TMS S.A.
2.1500
-2.93%
ZYXI Zynex, Inc.
2.1500
+3.86%
SIG.AX Sigma Healthcare Limited
3.0550
-0.16%
COSM Cosmos Health Inc.
0.4294
+2.24%